{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:24:53Z","timestamp":1777580693554,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Brain Research"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.molbrainres.2005.02.001","type":"journal-article","created":{"date-parts":[[2005,3,15]],"date-time":"2005-03-15T12:21:40Z","timestamp":1110889300000},"page":"177-188","source":"Crossref","is-referenced-by-count":33,"title":["NF-\u03baB mediates amyloid \u03b2 peptide-stimulated activity of the human apolipoprotein E gene promoter in human astroglial cells"],"prefix":"10.1016","volume":"136","author":[{"given":"Yansheng","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly R.","family":"Bales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin R.","family":"Farlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Wen","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debomoy K.","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molbrainres.2005.02.001_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nri1184","article-title":"Signalling pathways of the TNF superfamily: a double-edged sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat. Rev., Immunol."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1046\/j.1460-9568.2003.02869.x","article-title":"Non-steroidal anti-inflammatory drugs mediate increased in vitro glial expression of apolipoprotein E protein","volume":"18","author":"Aleong","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib3","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/hmg\/7.12.1887","article-title":"Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene","volume":"7","author":"Artiga","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-328X(98)00066-7","article-title":"The NF-kappaB\/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation","volume":"57","author":"Bales","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-4580(00)00143-3","article-title":"Neuroinflammation and Alzheimer's disease: critical roles for cytokine\/Abeta-induced glial activation, NF-kappaB, and apolipoprotein E","volume":"21","author":"Bales","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-510X(96)05335-X","article-title":"Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures","volume":"148","author":"Baskin","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib7","doi-asserted-by":"crossref","first-page":"43419","DOI":"10.1074\/jbc.M404937200","article-title":"Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma -secretase at a novel site-evidence for an allosteric mechanism","volume":"279","author":"Beher","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib8","doi-asserted-by":"crossref","first-page":"D34","DOI":"10.1093\/nar\/gki063","article-title":"GenBank","volume":"33","author":"Benson","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib9","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1128\/MCB.15.5.2809","article-title":"Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation","volume":"15","author":"Brockman","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1126\/science.7878466","article-title":"Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation","volume":"267","author":"Brown","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ng0198-69","article-title":"A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia","volume":"18","author":"Bullido","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib12","doi-asserted-by":"crossref","first-page":"9496","DOI":"10.1016\/S0021-9258(19)38877-5","article-title":"Characterization of a human apolipoprotein E gene enhancer element and its associated protein factors","volume":"265","author":"Chang","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/clinchem\/45.1.7","article-title":"New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases","volume":"45","author":"Chen","year":"1999","journal-title":"Clin. Chem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib14","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1046\/j.1471-4159.1999.0731453.x","article-title":"Sodium salicylate and 17beta-estradiol attenuate nuclear transcription factor NF-kappaB translocation in cultured rat astroglial cultures following exposure to amyloid A beta(1\u201340) and lipopolysaccharides","volume":"73","author":"Dodel","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.1997.69010299.x","article-title":"alpha2-Macroglobulin as a beta-amyloid peptide-binding plasma protein","volume":"69","author":"Du","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib16","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/brain\/awg191","article-title":"Human anti-beta-amyloid antibodies block beta-amyloid fibril formation and prevent beta-amyloid-induced neurotoxicity","volume":"126","author":"Du","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1172\/JCI200318162","article-title":"NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo","volume":"112","author":"Eriksen","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.1997.03540340056033","article-title":"Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons","volume":"277","author":"Evans","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1212\/01.WNL.0000125323.15458.3F","article-title":"Cholesterol and APOE genotype interact to influence Alzheimer disease progression","volume":"62","author":"Evans","year":"2004","journal-title":"Neurol"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib20","series-title":"Therapeutic applications of NSAIDs subpopulations and new formulations","author":"Famaey","year":"1992"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0197-4580(98)00096-7","article-title":"NSAIDs and incident Alzheimer's disease. The Rotterdam Study","volume":"19","author":"in 't Veld","year":"1998","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/jnr.10736","article-title":"Identity and function of gamma-secretase","volume":"74","author":"Kimberly","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib23","doi-asserted-by":"crossref","first-page":"6953","DOI":"10.1073\/pnas.84.19.6953","article-title":"Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro","volume":"84","author":"Kirschner","year":"1987","journal-title":"Proc. Natl. Acad. Sciences U. S. A."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1385-299X(00)00021-0","article-title":"Electrophoretic mobility shift assay for the detection of specific DNA\u2013protein complex in nuclear extracts from the cultured cells and frozen autopsy human brain tissue","volume":"5","author":"Lahiri","year":"2000","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1749-6632.2002.tb04662.x","article-title":"Functional characterization of the 5\u2032-regulatory region of the murine apolipoprotein gene","volume":"973","author":"Lahiri","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1385\/JMN:23:3:225","article-title":"Apolipoprotein e as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA, and regulatory region of the gene","volume":"23","author":"Lahiri","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neurobiolaging.2003.12.024","article-title":"Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease","volume":"25","author":"Lahiri","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib28","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/hmg\/7.9.1511","article-title":"Pronounced impact of Th1\/E47cs mutation compared with \u2212491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease","volume":"7","author":"Lambert","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib29","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1073\/pnas.89.17.8145","article-title":"The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor","volume":"89","author":"LeClair","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-0173(96)00014-8","article-title":"Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease","volume":"23","author":"Mattson","year":"1997","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1471-4159.1999.0721069.x","article-title":"Analysis of a novel mechanism of neuronal toxicity produced by an apolipoprotein E-derived peptide","volume":"72","author":"Moulder","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1212\/WNL.47.1.196","article-title":"A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the epsilon 4 allele","volume":"47","author":"Mui","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib34","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1101\/gr.146900","article-title":"Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene","volume":"10","author":"Nickerson","year":"2000","journal-title":"Genome Res."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1096\/fj.04-2637fje","article-title":"Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease","volume":"19","author":"Ohyagi","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib36","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.82.10.3445","article-title":"Nucleotide sequence and structure of the human apolipoprotein E gene","volume":"82","author":"Paik","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib37","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0092-8674(94)90482-0","article-title":"The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B","volume":"78","author":"Palombella","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/1389450043345272","article-title":"Metal and inflammatory targets for Alzheimer's disease","volume":"5","author":"Rogers","year":"2004","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib39","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1046\/j.1471-4159.2003.01788.x","article-title":"Microglial apolipoprotein E and astroglial apolipoprotein J expression in vitro: opposite effects of lipopolysaccharide","volume":"85","author":"Saura","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib40","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","article-title":"Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease","volume":"90","author":"Schmechel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev.ne.17.030194.002421","article-title":"Normal and abnormal biology of the beta-amyloid precursor protein","volume":"17","author":"Selkoe","year":"1994","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-2990.1996.tb01112.x","article-title":"Apolipoprotein E distribution among different plaque types in Alzheimer's disease: implications for its role in plaque progression","volume":"22","author":"Sheng","year":"1996","journal-title":"Neuropathol. App. Neurobiol."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib43","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1523\/JNEUROSCI.18-09-03261.1998","article-title":"Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins","volume":"18","author":"Sun","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib44","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.1002\/j.1460-2075.1994.tb06878.x","article-title":"A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B","volume":"13","author":"Traenckner","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib45","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/j.1460-2075.1995.tb07287.x","article-title":"Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli","volume":"14","author":"Traenckner","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib46","doi-asserted-by":"crossref","first-page":"10424","DOI":"10.1021\/bi990718v","article-title":"Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations","volume":"38","author":"Tseng","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(95)11763-M","article-title":"ApoE immunoreactivity and microglial cells in Alzheimer's disease brain","volume":"195","author":"Uchihara","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1567205043480546","article-title":"The effects of gender and CYP46 and ApoE polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins","volume":"1","author":"Vega","year":"2004","journal-title":"Curr. Alzheimer's Res."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib49","first-page":"1030","article-title":"Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro","volume":"145","author":"Wisniewski","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.55782\/ane-1996-1132","article-title":"Molecular biology of brain aging and neurodegenerative disorders","volume":"56","author":"Wisniewski","year":"1996","journal-title":"Acta Neurobiol. Exp. (Warsaw)"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib51","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","article-title":"Specific regional transcription of apolipoprotein E in human brain neurons","volume":"154","author":"Xu","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000051236","article-title":"High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease","volume":"12","author":"Yamagata","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.molbrainres.2005.02.001_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib54","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1097\/00001756-200108280-00011","article-title":"Enhanced expression of I-kappaB with neurofibrillary pathology in Alzheimer's disease","volume":"12","author":"Yoshiyama","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.molbrainres.2005.02.001_bib55","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/exnr.1997.6709","article-title":"Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning","volume":"149","author":"Zarow","year":"1998","journal-title":"Exp. Neurol."}],"container-title":["Molecular Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169328X05000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169328X05000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T02:28:53Z","timestamp":1706063333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169328X05000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":55,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0169328X05000422"],"URL":"https:\/\/doi.org\/10.1016\/j.molbrainres.2005.02.001","relation":{},"ISSN":["0169-328X"],"issn-type":[{"value":"0169-328X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}